From https://covid19treatmentguidelines.nih.gov
This caught my eye:
Considerations for Certain Concomitant Medications in Patients with COVID-19 Summary Recommendations
Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs):
Persons with COVID-19 who are prescribed ACE inhibitors or ARBs for cardiovascular disease (or other indications) should continue these medications (AIII).
The COVID-19 Treatment Guidelines Panel (the Panel) recommends against the use of ACE inhibitors or ARBs for the treatment of COVID-19 (emphasis added) outside of the setting of a clinical trial (AIII).
What exactly are they saying? Are they saying that ACE inhibitors or ARBs are being used by some doctors for treatment of COVID-19? Wasn't the thought that ACE inhibitors could be a potential liability if infected with COVID-19?
I take lovenox for hbp, which is a ACE inhibitor. I haven’t caught the ‘rona yet!
Agreed. I have wondered that.
There have been back-and-forth opposing studies on this for the last decade or more, regarding ACE inhibitors and ARBs, and influence on ACE2 proliferation and binding and things haven’t gotten any less confusing since the advent of Covid-19.